Understanding food and drug administration (FDA) regulatory requirements for investigational new drug applications (IND) for sponsor-investigators

Research output: Chapter in Book/Report/Conference proceedingChapter

Original languageEnglish (US)
Title of host publicationClinical Research
Subtitle of host publicationFrom Proposal to Implementation
PublisherWolters Kluwer Health Adis (ESP)
Pages132-146
Number of pages15
ISBN (Electronic)9781451153354
ISBN (Print)1605477486, 9781605477480
StatePublished - Jan 1 2012

Fingerprint

Investigational New Drug Application
United States Food and Drug Administration
Research Personnel

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Holbein, M. E. B. (2012). Understanding food and drug administration (FDA) regulatory requirements for investigational new drug applications (IND) for sponsor-investigators. In Clinical Research: From Proposal to Implementation (pp. 132-146). Wolters Kluwer Health Adis (ESP).

Understanding food and drug administration (FDA) regulatory requirements for investigational new drug applications (IND) for sponsor-investigators. / Holbein, M. E.Blair.

Clinical Research: From Proposal to Implementation. Wolters Kluwer Health Adis (ESP), 2012. p. 132-146.

Research output: Chapter in Book/Report/Conference proceedingChapter

Holbein, MEB 2012, Understanding food and drug administration (FDA) regulatory requirements for investigational new drug applications (IND) for sponsor-investigators. in Clinical Research: From Proposal to Implementation. Wolters Kluwer Health Adis (ESP), pp. 132-146.
Holbein MEB. Understanding food and drug administration (FDA) regulatory requirements for investigational new drug applications (IND) for sponsor-investigators. In Clinical Research: From Proposal to Implementation. Wolters Kluwer Health Adis (ESP). 2012. p. 132-146
@inbook{16a417652a38474b9e11669074a31e82,
title = "Understanding food and drug administration (FDA) regulatory requirements for investigational new drug applications (IND) for sponsor-investigators",
author = "Holbein, {M. E.Blair}",
year = "2012",
month = "1",
day = "1",
language = "English (US)",
isbn = "1605477486",
pages = "132--146",
booktitle = "Clinical Research",
publisher = "Wolters Kluwer Health Adis (ESP)",

}

TY - CHAP

T1 - Understanding food and drug administration (FDA) regulatory requirements for investigational new drug applications (IND) for sponsor-investigators

AU - Holbein, M. E.Blair

PY - 2012/1/1

Y1 - 2012/1/1

UR - http://www.scopus.com/inward/record.url?scp=85050188666&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85050188666&partnerID=8YFLogxK

M3 - Chapter

SN - 1605477486

SN - 9781605477480

SP - 132

EP - 146

BT - Clinical Research

PB - Wolters Kluwer Health Adis (ESP)

ER -